213 related articles for article (PubMed ID: 10508019)
1. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.
Onodera Y; Sato K
Antimicrob Agents Chemother; 1999 Oct; 43(10):2423-9. PubMed ID: 10508019
[TBL] [Abstract][Full Text] [Related]
2. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
[TBL] [Abstract][Full Text] [Related]
3. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
[TBL] [Abstract][Full Text] [Related]
4. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
Pan XS; Fisher LM
J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
[TBL] [Abstract][Full Text] [Related]
6. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
8. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance.
Hopewell R; Oram M; Briesewitz R; Fisher LM
J Bacteriol; 1990 Jun; 172(6):3481-4. PubMed ID: 2160946
[TBL] [Abstract][Full Text] [Related]
9. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
11. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
Kureishi A; Diver JM; Beckthold B; Schollaardt T; Bryan LE
Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
Peterson ML; Rotschafer JC; Piddock LJ
J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
[TBL] [Abstract][Full Text] [Related]
13. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Aleixandre V; Urios A; Herrera G; Blanco M
Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
Cullen ME; Wyke AW; Kuroda R; Fisher LM
Antimicrob Agents Chemother; 1989 Jun; 33(6):886-94. PubMed ID: 2548439
[TBL] [Abstract][Full Text] [Related]
15. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W
Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580
[TBL] [Abstract][Full Text] [Related]
17. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
18. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
[TBL] [Abstract][Full Text] [Related]
19. Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.
Bachoual R; Dubreuil L; Soussy CJ; Tankovic J
Antimicrob Agents Chemother; 2000 Jul; 44(7):1842-5. PubMed ID: 10858340
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance.
Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
